findmyKOL

Karen Mark, MD, MPH

Basic profile

Infectious Disease

ORCIDNone on fileNPI
RegionSacramento, CA · WestSpecialtyInfectious DiseaseFocusInfectious Disease
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPaymentsNone reportedNIH funding2011–2016Why? →

Karen Mark is an Infectious Disease physician. OpenAlex indexes 29 publications with 1,117 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
29publications

Distinct works indexed by OpenAlex.

1,117citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5NIH grants · 2011–2016

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1500 21st St
Sacramento, CA 958115216

Telephone

916-443-3299

Registry record last updated 23 Nov 2011.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    61.4%
    Statin27.6%
    Atorvastatin Calcium53%Pravastatin Sodium24%Rosuvastatin Calcium24%
    Part D<11 patients
    ACE inhibitor19.1%
    Lisinopril100%
    Part D<11 patients

    + 1 more class in this area

  • Anti-infectives

    18.3%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor12.6%
    Juluca58%Isentress Hd42%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor5.7%
    Triumeq100%
    Part D<11 patients
  • Respiratory

    14.2%
    beta2-Adrenergic Agonist14.2%
    Albuterol Sulfate Hfa100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

5 NIH research awards on record, funded 20112016 per NIH RePORTER. The latest:

9 more award records behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”